- Home
- XELLL vs LFMDP Comparison
XELLL vs LFMDP Comparison
Compare XELLL & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$23.14
Company Overview
Basic Information| Metric | XELLL | LFMDP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Nursing Services |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2003 | 2012 |
Fundamental Metrics
Financial Performance| Metric | XELLL | LFMDP |
|---|---|---|
| Price | $21.10 | $23.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 76.5K | 1.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ 1.82 | N/A |
| Revenue | ★ $11,537,000,000.00 | $12,468,578.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.61 | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $20.90 | $18.50 |
| 52 Week High | $25.59 | $24.20 |
Technical Indicators
Market Signals| Indicator | XELLL | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | 21.92 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $24.98 | N/A |
| Average True Range (ATR) | 0.48 | 0.00 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 10.73 | 0.00 |
Price Performance
Historical Comparison XELLL
LFMDP
About LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.